Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VERACYTE, INC. | 76,988 | reported | 03 Mar 2022 | tx 9+244,589−10,695 |
| Aurinia Pharmaceuticals Inc. | 63,724 | reported | 16 May 2025 | tx 1+63,724 |
| CELLEGY PHARMACEUTICALS INC | 35,000 | reported | 16 Oct 2013 | tx 5+174,776 |
| Azenta, Inc. | 15,772 | reported | 06 Feb 2026 | tx 4+13,307−2,465 |
| CYPRESS BIOSCIENCE INC | 15,000 | reported | 04 Jan 2010 | tx 5+80,000 |
| NanoString Technologies Inc | 14,451 | reported | 29 Apr 2014 | tx 1+14,451 |
| EXAGEN INC. | 13,500 | reported | 10 Jun 2025 | tx 7+81,113 |
| OPGEN INC | 750 | reported | 02 Sept 2019 | tx 4+45,750 |
| GENOPTIX INC | 25 | reported | 07 Mar 2011 | tx 84+593,324−1,034,182 |
| ARENA PHARMACEUTICALS INC | 0 | reported | 11 Mar 2022 | tx 44+613,176−169,845 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Feb 2026 | GRANT_AWARD | Azenta, Inc. | 5,663 | 27.85 USD | |
| 10 Jun 2025 | GRANT_AWARD | EXAGEN INC. | 13,500 | 0.00 USD | deriv |
| 16 May 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 63,724 | 0.00 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | Azenta, Inc. | 4,040 | 52.32 USD | |
| 10 Jun 2024 | GRANT_AWARD | EXAGEN INC. | 13,500 | 0.00 USD | deriv |
| 12 Feb 2024 | GRANT_AWARD | Azenta, Inc. | 2,465 | 65.93 USD | |
| 15 Jun 2023 | GRANT_AWARD | EXAGEN INC. | 13,500 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Azenta, Inc. | 3,604 | 0.00 USD | |
| 16 Jun 2022 | GRANT_AWARD | EXAGEN INC. | 9,000 | 0.00 USD | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 17,776 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 3,067 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 4,800 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 15,000 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 5,000 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 5,000 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 5,000 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 7,202 | — | deriv |
| 03 Mar 2022 | GRANT_AWARD | VERACYTE, INC. | 56,546 | 0.00 USD | |
| 03 Mar 2022 | GRANT_AWARD | VERACYTE, INC. | 103,043 | 0.00 USD | deriv |
| 02 Mar 2022 | TAX_WITHHOLDING | VERACYTE, INC. | 10,695 | 27.84 USD | |
| 17 Jun 2021 | GRANT_AWARD | EXAGEN INC. | 9,000 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | ARENA PHARMACEUTICALS INC | 3,067 | 0.00 USD | |
| 11 Jun 2021 | GRANT_AWARD | ARENA PHARMACEUTICALS INC | 7,202 | 0.00 USD | deriv |
| 26 Aug 2020 | EXERCISE | ARENA PHARMACEUTICALS INC | 1,200 | 14.90 USD | |
| 26 Aug 2020 | EXERCISE | ARENA PHARMACEUTICALS INC | 3,600 | 12.70 USD |